BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22499074)

  • 1. Relationship of HLA-DRB1 alleles with hepatocellular carcinoma development in chronic hepatitis B patients.
    Jin YJ; Shim JH; Chung YH; Kim JA; Choi JG; Park WH; Lee D; Lee YS; Kim SE; Kim SH; Yang SH
    J Clin Gastroenterol; 2012; 46(5):420-6. PubMed ID: 22499074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB1*010101 allele is closely associated with poor virological response to lamivudine therapy in patients with chronic hepatitis B.
    Jin YJ; Shim JH; Chung YH; Kim JA; Choi JG; Park WH; Lee D; Kim SE; Lee YS; Kim SH; Yang SH
    Digestion; 2011; 84 Suppl 1():35-42. PubMed ID: 22156484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.
    De Re V; Caggiari L; Talamini R; Crovatto M; De Vita S; Mazzaro C; Cannizzaro R; Dolcetti R; Boiocchi M
    Hum Immunol; 2004 Nov; 65(11):1397-404. PubMed ID: 15556690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.
    El-Chennawi FA; Auf FA; Metwally SS; Mosaad YM; El-Wahab MA; Tawhid ZE
    Immunol Invest; 2008; 37(7):661-74. PubMed ID: 18821214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.
    Ramezani A; Hasanjani Roshan MR; Kalantar E; Eslamifar A; Banifazl M; Taeb J; Aghakhani A; Gachkar L; Velayati AA
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1716-21. PubMed ID: 18761557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of polymorphism on HLA-DRB1*04 alleles with outcome of hepatitis B virus infection].
    Song MS; Li HW; Peng HY; Duan BN; Chen H; Xu LQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):467-9. PubMed ID: 17680546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen class I alleles and haplotypes associated with primary hepatocellular carcinoma in persistent HBV-infected patients.
    Pan N; Chen K; Qiu J; Sun H; Xu J; Miao F; Shi Q; Jiang W; Jin H; He Y; Xie W; Zhang J
    Hum Immunol; 2013 Jun; 74(6):758-63. PubMed ID: 23459080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a histocompatibility antigen related to hepatitis B virus in patients with hepatocellular carcinoma in the western Brazilian Amazon.
    Chalub SR; da Silva RM; da Silva AP; de Aquino PF; Sadahiro A; Kalil AN
    Genet Mol Res; 2013 Apr; 12(2):1336-46. PubMed ID: 23661457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological characteristics predisposing to development of hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee SH; Chung YH; Kim JA; Jin YJ; Park WH; Choi JG; Lee D; Shim JH; Yu E; Jang MK
    J Clin Pathol; 2011 Jul; 64(7):599-604. PubMed ID: 21572113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.
    Kozuka R; Enomoto M; Sato-Matsubara M; Yoshida K; Motoyama H; Hagihara A; Fujii H; Uchida-Kobayashi S; Morikawa H; Tamori A; Kawada N; Murakami Y
    J Gastroenterol Hepatol; 2019 May; 34(5):937-946. PubMed ID: 30160782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma.
    Kim JH; Park JW; Koh DW; Lee WJ; Kim CM
    Liver Int; 2009 Feb; 29(2):203-7. PubMed ID: 18662281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
    Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
    Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
    Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.
    Huang YW; Hu CY; Chen CL; Liao YT; Liu CJ; Lai MY; Chen PJ; Yang SS; Hu JT; Chen DS; Kao JH
    J Med Virol; 2009 Apr; 81(4):588-93. PubMed ID: 19235869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA-DRB1 gene polymorphisms with hepatocellular carcinoma risk: a meta-analysis.
    Liu L; Guo W; Zhang J
    Minerva Med; 2017 Apr; 108(2):176-184. PubMed ID: 27808488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen (HLA) class II association in chronic hepatitis B patients with hepatocellular carcinoma in a Malay population: A pilot study.
    Krishnan PB; Abdullah M; Hudu SA; Sekawi Z; Tan SS; Amin-Nordin S
    Trop Biomed; 2019 Sep; 36(3):703-708. PubMed ID: 33597492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population.
    Deng Y; Li P; Liu W; Pu R; Yang F; Song J; Yin J; Han X; Li C; Zhao J; Wang H; Cao G
    J Viral Hepat; 2020 Nov; 27(11):1150-1161. PubMed ID: 32568442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The association of HLA-DRB1 allele polymorphism with the genetic susceptibility to liver cirrhosis due to hepatitis B virus].
    Cheng YQ; Lin JS; Huang LH; Tian DY; Xiong P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):247-9. PubMed ID: 12778456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.